Clindamycin-resistant Clostridium perfringens cellulitis
Author:
- 1 August 2008
- journal article
- case report
- Published by Elsevier in Journal of Tissue Viability
- Vol. 17 (3) , 95-97
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999–2003Journal of Antimicrobial Chemotherapy, 2006
- Recurrent crepitant cellulitis caused by Clostridium perfringensThe Pediatric Infectious Disease Journal, 2002
- Anaerobic cellulitis as the result of Clostridium perfringens: A rare cause of vascular access graft infectionJournal of Vascular Surgery, 2002
- Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Virulence studies on chromosomal α‐toxin and Θ‐toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α‐toxin in Clostridium perfringens‐mediated gas gangreneMolecular Microbiology, 1995
- Molecular genetics and pathogenesis of Clostridium perfringens.Microbiological Reviews, 1991
- Comparison of Clindamycin, Rifampin, Tetracycline, Metronidazole, and Penicillin for Efficacy in Prevention of Experimental Gas Gangrene Due to Clostridium perfringensThe Journal of Infectious Diseases, 1987